Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.48 EXHIBIT10.48_CELL_BANKING_AGREEMENT_GREEN_HOSPITAL
- 10.49 EXHIBIT10.49_OLYMPUS_CYTORI_LICENSE_AGREEMENT
- 10.50 Exhibit 10.50_RANSOM_RELEASE_AGREEMENT
- 15.1 Exhibit 15.1_AUDITOR Consent
- 31.1 Exhibit 31.1_SECTION 302_CEO Certification
- 31.2 Exhibit 31.2_SECTION 302_CFO Certification
- 32.1 Exhibit 32.1_SECTION 906 Certification
PSTV similar filings
Filing view
External links
EXHIBIT 15.1
Letter re: Unaudited Interim Financial Information
November 13, 2007
Cytori Therapeutics, Inc.
3020 Callan Road
San Diego, California 92121
Re: Registration Statement Nos. 333-82074, 333-122691, 333-134129, and 333-140875
With respect to the subject registration statements, we acknowledge our awareness of the use therein of our report dated November 9, 2007, related to our review of interim financial information.
Pursuant to Rule 436 under the Securities Act of 1933 (the Act), such report is not considered part of a registration statement prepared or certified by an independent registered public accounting firm, or a report prepared or certified by an independent registered public accounting firm within the meaning of Sections 7 and 11 of the Act.
/s/ KPMG LLP | |
San Diego, California |